is semaglutide more effective than tirzepatide vs. Semaglutide: What You Should Know Tirzepatide And Semaglutide: Experts Explain

If recurrent hypoglycaemia occurs, review and consider reducing insulin or sulfonylurea doses under clinician guidance

Retatrutide is not FDA-approved for clinical use and is intended for **research purposes only** under professional supervision

Directly suppresses appetite at the cerebral level

Standard high-dose delivery methods (such as some autoinjectors) may increase the likelihood of side effects if not tailored to the individual

We are committed to being your partner in this process

Cardiovascular outcomes associated with SGLT-2 inhibitors versus other glucose-lowering drugs in patients with type 2 diabetes: a real-world systematic review and meta-analysis